NCT00193011 Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer Status COMPLETED Phase PHASE3
NCT00191672 A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00191490 A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00191438 Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents Status COMPLETED Phase PHASE3
NCT00191152 A Phase III Trial For Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00191139 Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00183937 Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer Status TERMINATED Phase PHASE2
NCT00183924 Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. Status COMPLETED Phase PHASE2
NCT00179309 Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer Status COMPLETED Phase PHASE2
NCT00178269 Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix Status COMPLETED Phase PHASE2
NCT00177255 A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers Status TERMINATED Phase PHASE2
NCT00176631 Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Status TERMINATED Phase PHASE2
NCT00176527 Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Status TERMINATED Phase PHASE2
NCT00169520 SB-715992 In Combination With Docetaxel In Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00169182 Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma Status COMPLETED Phase PHASE3
NCT00169000 Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers Status COMPLETED Phase PHASE1
NCT00167401 Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00165399 Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment Status COMPLETED Phase PHASE2
NCT00156312 Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine Status COMPLETED Phase NA